Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to examine the level of ovarian response and the
pregnancy rates among poor ovarian responders treated with a novel treatment protocol with
150μg corifollitropin alfa followed by 300IU hMG in a short GnRH agonist protocol.